Day One Biopharmaceuticals Inc — Cash Flow (NASDAQ:DAWN) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 48.54 M109.87 M146.85 M78.11 M103.76 M 103.76 M Cash from investing activities 8 M255.07 M128.38 M230.99 M174.65 M 174.65 M Cash from financing activities 297.12 M165.9 M164 M203.29 M1.22 M 1.22 M Free cash flow 48.54 M109.85 M146.63 M58.84 M99.94 M 99.94 M

新闻

Needham因成本因素下调Day One Biopharmaceuticals目标价

Needham lowers Day One Biopharmaceuticals price target on costs

H.C. Wainwright下调Day One Biopharmaceuticals目标价至22美元

H.C. Wainwright lowers Day One Biopharmaceuticals price target to $22

Day One Biopharmaceuticals, Inc. (DAWN) Q4 2025 Earnings Call Transcript

Day One Biopharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:DAWN) 2026-02-25

Day One Biopharmaceuticals Q4 每股收益逊于预期, 营收超出预期

Day One Biopharmaceuticals earnings missed by $0.02, revenue topped estimates

Day One Biopharmaceuticals营收超预期

Day One Biopharmaceuticals beats revenue estimates

Day One Biopharmaceuticals公布业绩在即,此前刚完成Mersana收购交易

Day one Biopharma CCO sold $67k in DAWN stock